DanCann Pharma A/S: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S
The Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Tuesday, 20 June 2023 at 09:00 am (CET) at DanCann Pharma A/S’ address, Rugvænget 5, 6823 Ansager, Denmark The agenda for the extraordinary general meeting is as follows: 1. 1. 1. 1. 1. 1. 1. Proposed resolution to authorise the Board of Directors to increase the share capital without pre-emption rights for the Company’s shareholders. (proposed by the board of directors)